MAPK3 and fatty liver disease: Last but not least, approaches targeting MAPK3 (also known as extracellular signal-regulated kinase 1, ERK1) partially protect obese mice from insulin resistance and hepatic steatosis by decreasing adipose tissue inflammation and by increasing muscle glucose uptake [55].